NCT06588907

Brief Summary

The aim is to evaluate the success of reduction procedures and pain palliation in patients with forearm fractures undergoing reduction under procedural sedation-analgesia (PSA) and ultrasound (US)-guided infraclavicular nerve block (ICB) in the emergency department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 8, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

July 8, 2024

Last Update Submit

December 22, 2024

Conditions

Keywords

Procedural sedation-analgesiainfraclavicular nerve block

Outcome Measures

Primary Outcomes (3)

  • Evaluation of patients' pain levels according to the Numerical Rating Scale (NRS) after the applied protocols.

    Pain levels at arrival, pre-reduction procedure, and post-reduction procedure will be recorded using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain).

    1. Pain level at the 1. minute upon presentation to the emergency room. 2. Pain level after the implementation of the protocols, i.e. 1 hour later. 3. Pain level 24 hours after the procedure.

  • Success of reduction following the applied protocols.

    The success of the reduction procedure, whether further reduction attempts were necessary, and findings from post-reduction control X-rays (radial height, radial tilt, and volar tilt) will be noted and evaluated by orthopedic physicians.

    An x-ray will be taken before the reduction process, i.e. at 10 minutes. An x-ray will be taken at 1 hour after the reduction process.

  • Evaluation of the need for additional rescue treatments during the procedure.

    If NRS is above 5, as first-line rescue analgesia, tramadol 50 or 100 mg IV diluted in 100 mL normal saline will be administered over 15 minutes. If pain persists above NRS 5, second-line treatment with 50 mcg fentanyl diluted in 100 mL normal saline will be administered over 15 minutes.

    Rescue analgesia will be administered if NRS is above 5 fifteen minutes after the protocols are applied.

Secondary Outcomes (1)

  • Patient and practitioner satisfaction with the reduction procedure.

    The satisfaction survey for both the patient and the reduction practitioner will be conducted 30 minutes after the reduction procedure.

Study Arms (2)

Group P

ACTIVE COMPARATOR

Reduction will be performed under procedural sedation analgesia (PSA)

Drug: Ketamine

Group B

ACTIVE COMPARATOR

Reduction will be performed under ultrasound-guided infraclavicular nerve block (ICB).

Drug: Bupivacaine Hydrochloride

Interventions

After preparing the infraclavicular block site, a 22-gauge needle, guided by ultrasound, will be placed in the 6-7 o'clock position in the same plane as the ultrasound probe. Subsequently, lateral, medial, and posterior cords described as hypoechoic nerve fascicles within hyperechoic structures will be identified. Initially, 2 mL of saline will be administered to confirm proper spread. Once confirmed, 20 mL of 0.25% bupivacaine (prepared by diluting 10 mL of 0.5% bupivacaine with 10 mL of normal saline) will be injected in fractional doses with intermittent negative aspiration. Fifteen minutes after this procedure, anesthesia depth will be assessed using a cold-hot test, followed by reduction and application of the cast.

Also known as: Infraclavicular nerve block (ICB)
Group B

Until the recovery period, patients will be closely monitored by an experienced doctor or nurse during sedation. Emergency equipment will be readily available in case of any complications. The following protocol will be used for procedural sedation-analgesia (PSA): Ketamine will be administered intravenously at a dose of 0.5-1 mg/kg. Patients with Numeric Rating Scale (NRS) scores above 5 may receive additional doses of 0.25-1 mg/kg, repeated every 5 to 10 minutes as needed.

Also known as: procedural sedation-analgesia
Group P

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years and older,
  • Diagnosed with forearm fracture using standard radiography,
  • Hemodynamically stable individuals,
  • Without vascular or nerve injury,
  • Without infection in the skin or tissues where the needle will pass,
  • Able to provide written and verbal consent and are capable of giving consent

You may not qualify if:

  • Those with allergies to drugs used for sedoanalgesia and peripheral nerve blockade,
  • Those who are hemodynamically unstable,
  • Patients with ASA (American Society of Anesthesiologists) classification 3-4 will not be included in the group for whom PSA will be applied,
  • Patients with coagulopathy, liver, or kidney failure,
  • Patients with opioid, alcohol, or substance dependency,
  • Those with skin infections or open wounds in the area where local anesthetic will be administered,
  • Pregnant or suspected pregnant individuals,
  • Those who do not provide written and verbal consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, 38000, Turkey (Türkiye)

Location

Related Publications (4)

  • Fauteux-Lamarre E, Burstein B, Cheng A, Bretholz A. Reduced Length of Stay and Adverse Events Using Bier Block for Forearm Fracture Reduction in the Pediatric Emergency Department. Pediatr Emerg Care. 2019 Jan;35(1):58-62. doi: 10.1097/PEC.0000000000000963.

    PMID: 27918376BACKGROUND
  • Tekin E, Aydin ME, Turgut MC, Karagoz S, Ates I, Ahiskalioglu EO. Can ultrasound-guided infraclavicular block be an alternative option for forearm reduction in the emergency department? A prospective randomized study. Clin Exp Emerg Med. 2021 Dec;8(4):307-313. doi: 10.15441/ceem.20.136. Epub 2021 Dec 31.

  • Kukreja P, Kofskey AM, Ransom E, McKenzie C, Feinstein J, Hudson J, Kalagara H. Comparison of Supraclavicular Regional Nerve Block Versus Infraclavicular Regional Nerve Block in Distal Radial Open Reduction and Internal Fixation: A Retrospective Case Series. Cureus. 2022 Apr 12;14(4):e24079. doi: 10.7759/cureus.24079. eCollection 2022 Apr.

  • Sarcan E, Erdem AB, Uysal SB, Duman E, Cebeci Z, Arik E. Pain management with ketamine procedural sedation and infraclavicular block for forearm fracture in the emergency department. Am J Emerg Med. 2025 Oct;96:256-263. doi: 10.1016/j.ajem.2025.07.012. Epub 2025 Jul 16.

MeSH Terms

Conditions

Radius FracturesUlna Fractures

Interventions

BupivacaineKetamine

Condition Hierarchy (Ancestors)

Forearm InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbons

Study Officials

  • Ahmet Burak Erdem

    Ankara Etlik City Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 8, 2024

First Posted

September 19, 2024

Study Start

June 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 15, 2024

Last Updated

December 27, 2024

Record last verified: 2024-12

Locations